Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
biosimulytics logo — AI-powered molecular modelling for accelerated and smarter d...

biosimulytics

AI-powered molecular modelling for accelerated and smarter drug development

Founded 2019 Ireland Ireland 7 employees Grant Total: $595.00K AI, Pharmaceutical +1

General Information

Company Name biosimulytics
Founded Year 2019
Location Ireland Ireland +1
Employees 7
Industries AI, Pharmaceutical, Machine Learning
Funding Stage Grant
Social

Get notified when biosimulytics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About biosimulytics

BioSimulytics is an AI-powered molecular modelling startup focused on revolutionizing the drug development process. Founded in 2019 as a spin-out from the School of Chemical & Bioprocess Engineering of University College Dublin (UCD) in Ireland, the company leverages advanced neural network technology, molecular modelling, quantum physics, and high-performance computing to advance next-generation drug development in the pharma/biotech sector. A key focus is on rapidly predicting polymorphism, a known challenge in the pharmaceutical industry. Additionally, the technology is applied to predicting stable binding poses in protein-ligand complexes for structure-based drug design. The company secured a grant investment from EIC Accelerator on 20 June 2023, demonstrating investor confidence in their innovative approach. BioSimulytics aims to address pressing healthcare needs by unlocking new and improved therapies faster and more cost-efficiently.

Taxonomy: AI-powered technology, Molecular modelling, Drug development, Neural network technology, Quantum physics, High performance computing, Pharma/biotech sector, Therapy optimization, Healthcare innovation, Polymorphism prediction, Structure-based drug design, Software development, University spin-out, Research and development

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 20 Jun 2023
Seed Round •••••• 1
Investor
02 Sep 2021

Latest News

View All
Europe's most promising innovations to compete for up to 50,000 EUR at the EIT Awards 2024 [Advertor... — Tech
Europe's most promising innovations to compete for up to 50,000 EUR at the EIT Awards 2024 [Advertorial]
Tech Feb 19, 2024
A showcase of Europe's impact-driven innovators – EIT Awards winners announced [Advertorial] — Tech
A showcase of Europe's impact-driven innovators – EIT Awards winners announced [Advertorial]
Tech Feb 22, 2024

biosimulytics Alternatives & Competitors

biosimulytics vs
iktos
iktos France

Artificial intelligence for new drug design

Series A
85 employees
AI, Biotechnology
biosimulytics vs
EIT Manufacturing
EIT Manufacturing France

Our purpose is to improve people’s lives through sustainable manufacturing.

267 employees
Manufacturing
biosimulytics vs
RES Group, Inc
RES Group, Inc United States

Mechanistic modeling & simulation services to accelerate R&D in drug development

24 employees
Energy, Pharmaceutical

FAQ About biosimulytics

AI-powered molecular modelling for accelerated and smarter drug development
biosimulytics was founded in 2019.
biosimulytics is headquartered in Ireland.
biosimulytics operates in the following industries: AI, Pharmaceutical, Machine Learning.
biosimulytics has approximately 7 employees.
biosimulytics has completed 2 funding rounds, raising a total of $595.00K. The latest funding stage is Grant.
Top alternatives and competitors to biosimulytics include iktos, EIT Manufacturing, RES Group, Inc, Intrepid Labs, Yuyao Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
biosimulytics and iktos are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors biosimulytics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy